Biovail Faces Grand Jury Probe On Cardizem Launch
The U.S. attorney's office in Boston is now pursuing a grand jury investigation into Biovail Corp.'s launch of the hypertension drug Cardizem(R) LA, a move that has already come under scrutiny...To view the full article, register now.
Already a subscriber? Click here to view full article